KA
Kintegral Advisory’s Eli Lilly LLY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.8M | Sell |
16,390
-25
| -0.2% | -$19.5K | 1.16% | 15 |
|
|
2025
Q1 | $13.6M | Sell |
16,415
-56
| -0.3% | -$46.3K | 1.37% | 9 |
|
|
2024
Q4 | $12.7M | Sell |
16,471
-768
| -4% | -$593K | 1.2% | 11 |
|
|
2024
Q3 | $15.3M | Sell |
17,239
-226
| -1% | -$200K | 1.4% | 6 |
|
|
2024
Q2 | $15.8M | Buy |
17,465
+1,570
| +10% | +$1.42M | 1.52% | 7 |
|
|
2024
Q1 | $12.4M | Sell |
15,895
-50
| -0.3% | -$38.9K | 1.24% | 12 |
|
|
2023
Q4 | $9.29M | Sell |
15,945
-102
| -0.6% | -$59.5K | 1.03% | 17 |
|
|
2023
Q3 | $8.62M | Sell |
16,047
-10
| -0.1% | -$5.37K | 1.06% | 16 |
|
|
2023
Q2 | $7.53M | Hold |
16,057
| – | – | 0.89% | 22 |
|
|
2023
Q1 | $5.51M | Sell |
16,057
-863
| -5% | -$296K | 0.71% | 36 |
|
|
2022
Q4 | $6.19M | Buy |
16,920
+5,900
| +54% | +$2.16M | 0.82% | 31 |
|
|
2022
Q3 | $3.56M | Hold |
11,020
| – | – | 0.49% | 52 |
|
|
2022
Q2 | $3.57M | Buy |
11,020
+233
| +2% | +$75.5K | 0.46% | 55 |
|
|
2022
Q1 | $3.09M | Buy |
10,787
+241
| +2% | +$69K | 0.34% | 77 |
|
|
2021
Q4 | $2.91M | Hold |
10,546
| – | – | 0.3% | 84 |
|
|
2021
Q3 | $2.44M | Hold |
10,546
| – | – | 0.29% | 82 |
|
|
2021
Q2 | $2.42M | Hold |
10,546
| – | – | 0.29% | 85 |
|
|
2021
Q1 | $1.97M | Hold |
10,546
| – | – | 0.25% | 99 |
|
|
2020
Q4 | $1.78M | Hold |
10,546
| – | – | 0.24% | 103 |
|
|
2020
Q3 | $1.56M | Sell |
10,546
-339
| -3% | -$50.2K | 0.24% | 103 |
|
|
2020
Q2 | $1.79M | Hold |
10,885
| – | – | 0.29% | 84 |
|
|
2020
Q1 | $1.51M | Buy |
10,885
+1,218
| +13% | +$169K | 0.29% | 88 |
|
|
2019
Q4 | $1.27M | Hold |
9,667
| – | – | 0.23% | 115 |
|
|
2019
Q3 | $1.08M | Hold |
9,667
| – | – | 0.22% | 126 |
|
|
2019
Q2 | $1.07M | Hold |
9,667
| – | – | 0.22% | 123 |
|
|
2019
Q1 | $1.25M | Sell |
9,667
-409
| -4% | -$53.1K | 0.26% | 108 |
|
|
2018
Q4 | $1.17M | Buy |
+10,076
| New | +$1.17M | 0.35% | 74 |
|